Sensus
1 known investors
Find your way into Sensus
Sign up to see every warm intro you have to Sensus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sensus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bough Bio develops therapies that target senescent cells in the brain to treat neurological and psychiatric diseases. The company focuses on clearing damaged cells to restore healthy brain function and address conditions related to stress-induced brain damage.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Sensus do?
- Bough Bio develops therapies that target senescent cells in the brain to treat neurological and psychiatric diseases. The company focuses on clearing damaged cells to restore healthy brain function and address conditions related to stress-induced brain damage.
- Who are Sensus's investors?
- Sensus's investors include CABHI Ventures.

